Evangelia Papadimitriou Selected Research

Class 5 Receptor-Like Protein Tyrosine Phosphatases

12/2016	Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer.
2/2016	Effects of mechanical loading on the expression of pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta in a rat spinal deformity model.
7/2013	Expression of the growth factor pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta in the serum, cartilage and subchondral bone of patients with osteoarthritis.
5/2009	Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta.
4/2009	Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evangelia Papadimitriou Research Topics

Disease

21	Neoplasms (Cancer) 01/2019 - 01/2002
9	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 10/2005
6	Glioma (Gliomas) 01/2013 - 09/2002
2	Neoplasm Metastasis (Metastasis) 06/2022 - 10/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2009
2	Carcinogenesis 01/2018 - 05/2014
2	Atherosclerosis 01/2016 - 02/2014
2	Osteoarthritis 09/2015 - 07/2013
1	Vaccine-Preventable Diseases 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Malaria 01/2017
1	Thrombosis (Thrombus) 12/2016
1	Cardiomegaly (Heart Hypertrophy) 12/2016
1	Hypertrophy 12/2016
1	Congenital Abnormalities (Deformity) 02/2016
1	Hyperplasia 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Pathologic Neovascularization 12/2014
1	Inflammation (Inflammations) 05/2014
1	Acute Promyelocytic Leukemia 01/2013
1	Acne Vulgaris 01/2013
1	Crimean Hemorrhagic Fever 03/2011
1	Nervous System Neoplasms (Neoplasms, Nervous System) 12/2009
1	Necrosis 08/2009
1	Hemorrhage 01/2009

Drug/Important Bio-Agent (IBA)

19	pleiotrophin (HARP)IBA 06/2022 - 06/2005
14	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2022 - 06/2005
8	Biological ProductsIBA 01/2017 - 10/2005
6	Heparin (Liquaemin)FDA LinkGeneric 12/2016 - 06/2005
5	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 12/2016 - 04/2009
4	NucleolinIBA 06/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 11/2004
2	Amino Acids FDA Link 06/2022 - 08/2009
2	Peptides (Polypeptides)IBA 06/2022 - 08/2009
2	IntegrinsIBA 08/2014 - 01/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013 - 08/2009
2	RetinoidsIBA 01/2013 - 08/2009
1	AntibodiesIBA 01/2020
1	matrigelIBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	artemisinin (artemisinine)IBA 01/2017
1	MyogeninIBA 12/2016
1	IvabradineIBA 01/2016
1	Simvastatin (Zocor)FDA LinkGeneric 01/2016
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2015
1	Epidermal Growth Factor (EGF)IBA 10/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2015
1	ErbB Receptors (EGF Receptor)IBA 10/2015
1	Matrix Metalloproteinase 12IBA 09/2015
1	Protein Tyrosine PhosphatasesIBA 08/2014
1	betaglycan (TGFBR3)IBA 08/2014
1	SyndecansIBA 08/2014
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 08/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2014
1	chondroitin sulfate proteoglycan 4IBA 08/2014
1	Neuropilin-1IBA 08/2014
1	LigandsIBA 05/2014
1	CholesterolIBA 02/2014
1	retinoic acid receptor betaIBA 01/2013
1	SpermineIBA 01/2013
1	Retinoic Acid Receptor alphaIBA 01/2013
1	Furocoumarins (Furanocoumarins)IBA 01/2013
1	Topoisomerase I InhibitorsIBA 06/2011
1	carbazoleIBA 06/2011
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2011
1	VaccinesIBA 03/2011
1	Annexin A5IBA 08/2009
1	Propidium (Propidium Iodide)IBA 08/2009
1	EstersIBA 08/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2009
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2009
1	Fibrinolysin FDA Link 01/2009
1	Aprotinin (Trasylol)FDA Link 01/2009
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2008
1	Cisplatin (Platino)FDA LinkGeneric 08/2007
1	monomethoxypolyethylene glycol (MPEG)IBA 08/2007
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2006
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2005
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2005
1	Monoterpenes (Monoterpenoids)IBA 11/2004
1	perillyl alcoholIBA 11/2004
1	ParaffinIBA 09/2002
1	Amifostine (Ethyol)FDA LinkGeneric 09/2002
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2002
1	Arsenic Trioxide (Trisenox)FDA Link 01/2002
1	Liposomes (Liposome)IBA 01/2002
1	ArsenicIBA 01/2002

Therapy/Procedure

4	Therapeutics 01/2018 - 11/2004
1	Drug Therapy (Chemotherapy) 01/2019
1	Stents 12/2016
1	Radiotherapy 07/2004